Botox firm to deliver €65m lift for Ireland
Irish headquartered Botox-maker Allergan is investing €65m in two of its four Irish facilities, adding 63 high-skill jobs.
It has announced a €65m capital investment programme for 2019 to expand laboratories and manufacturing campuses in Westport, Co Mayo and at Clonshaugh, Co Dublin.
Please log in or register with Independent.ie for free access to this article.
The move will take total employment in Ireland to more than 2,000. One in 10 of Allergan's global workforce is based in Ireland.
Allergan's Westport campus is the company's largest and most complex and includes a pharmaceuticals facility, two biologics plants and an ocular implant facility. It produces the global supply of Botox as well as manufacturing medicines and eye care products.
Paul Coffey, vice president and plant general manager at Allergan Westport, said the latest investment cements Ireland's strategic role in Allergan's global network.
"Continued investment of this scale builds on the €50m investment programme in 2018 and €42m in 2017 which allows us to apply world-class technology to Allergan's leading innovation and product development strategy," he said.
The expansion was welcomed by Taoiseach Leo Varadkar, who said it reinforced Mayo's reputation as a location for investment and innovation.
The investment in Westport focuses on two new manufacturing suites in its biologics facility to provide the capability to introduce new product formats, and completion of a new state-of-the-art microbiology and cell-based laboratory.
Investment at the Clonshaugh site will focus on expanding specialised manufacturing capability.